These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 22483466)
1. Serum adiponectin levels in renal transplant recipients with and without metabolic syndrome. Shu KH; Tsai IC; Ho HC; Wu MJ; Chen CH; Cheng CH; Yu TM; Chuang YW; Huang ST Transplant Proc; 2012 Apr; 44(3):676-9. PubMed ID: 22483466 [TBL] [Abstract][Full Text] [Related]
2. Serum adipokine levels in renal transplant recipients. Shu KH; Wu MJ; Chen CH; Cheng CH; Yu TM; Chuang YW; Huang ST; Tsai SF; Lo YC; Weng SC; Wen MC; Ho HC Transplant Proc; 2014; 46(2):381-4. PubMed ID: 24655968 [TBL] [Abstract][Full Text] [Related]
3. Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation. Chitalia N; Raja RB; Bhandara T; Agrawal P; Kaski JC; Jha V; Banerjee D J Nephrol; 2010; 23(1):77-84. PubMed ID: 20091490 [TBL] [Abstract][Full Text] [Related]
4. Coronary artery calcification in kidney transplant recipients with long-term follow-up. Shu KH; Tsai IC; Ho HC; Wu MJ; Chen CH; Cheng CH; Yu TM; Chuang YW; Huang ST Transplant Proc; 2012 Apr; 44(3):687-90. PubMed ID: 22483469 [TBL] [Abstract][Full Text] [Related]
5. Hypoadiponectinemia correlates with metabolic syndrome in kidney transplantation patients. Lee MC; Lee CJ; Chou KC; Shih MH; Hsu BG Transplant Proc; 2011 Sep; 43(7):2601-5. PubMed ID: 21911131 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of the metabolic syndrome in kidney transplantation. Kishikawa H; Nishimura K; Kato T; Kobayashi Y; Arichi N; Okuno A; Fujii N; Kyo M; Takahara S; Ichikawa Y Transplant Proc; 2009; 41(1):181-3. PubMed ID: 19249509 [TBL] [Abstract][Full Text] [Related]
7. Anemia is associated with an elevated serum level of high-molecular-weight adiponectin in patients with type 2 diabetes independently of renal dysfunction. Aso Y; Suganuma R; Wakabayashi S; Hara K; Nakano T; Suetsugu M; Matsumoto S; Nakamachi T; Takebayashi K; Morita K; Inukai T Transl Res; 2009 Oct; 154(4):175-82. PubMed ID: 19766961 [TBL] [Abstract][Full Text] [Related]
8. Plasma adiponectin distribution in a Mediterranean population and its association with cardiovascular risk factors and metabolic syndrome. Salas-Salvadó J; Granada M; Bulló M; Corominas A; Casas P; Foz M Metabolism; 2007 Nov; 56(11):1486-92. PubMed ID: 17950098 [TBL] [Abstract][Full Text] [Related]
9. Adiponectin as a biomarker of clinical manifestation of metabolic syndrome. Tajtákova M; Petrásova D; Petrovicová J; Pytliak M; Semanová Z Endocr Regul; 2006 Mar; 40(1):15-9. PubMed ID: 16964963 [TBL] [Abstract][Full Text] [Related]
10. Low plasma levels of adiponectin are associated with low risk for future cardiovascular events in patients with clinical evident vascular disease. Hajer GR; van der Graaf Y; Olijhoek JK; Edlinger M; Visseren FL Am Heart J; 2007 Oct; 154(4):750.e1-7. PubMed ID: 17893004 [TBL] [Abstract][Full Text] [Related]
11. Relationship between serum free T4 (FT4) levels and metabolic syndrome (MS) and its components in healthy euthyroid subjects. Kim BJ; Kim TY; Koh JM; Kim HK; Park JY; Lee KU; Shong YK; Kim WB Clin Endocrinol (Oxf); 2009 Jan; 70(1):152-60. PubMed ID: 18494864 [TBL] [Abstract][Full Text] [Related]
12. Hyperleptinemia positively correlated with metabolic syndrome in renal transplant recipients. Lee MC; Lee CJ; Ho GJ; Lee CC; Shih MH; Chou KC; Hsu BG Clin Transplant; 2010; 24(4):E124-9. PubMed ID: 20236136 [TBL] [Abstract][Full Text] [Related]
13. Physical activity is associated with risk factors for chronic disease across adult women's life cycle. Woolf K; Reese CE; Mason MP; Beaird LC; Tudor-Locke C; Vaughan LA J Am Diet Assoc; 2008 Jun; 108(6):948-59. PubMed ID: 18502225 [TBL] [Abstract][Full Text] [Related]
14. The association between pulse wave velocity and metabolic syndrome and adiponectin in patients with impaired fasting glucose: cardiovascular risks and adiponectin in IFG. Nam JS; Park JS; Cho MH; Jee SH; Lee HS; Ahn CW; Lowe WL; Kim KR Diabetes Res Clin Pract; 2009 May; 84(2):145-51. PubMed ID: 19261346 [TBL] [Abstract][Full Text] [Related]
16. Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease. Zapolski T; Waciński P; Kondracki B; Rychta E; Buraczyńska MJ; Wysokiński A Kardiol Pol; 2011; 69(4):319-26. PubMed ID: 21523662 [TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events. Laryea M; Watt KD; Molinari M; Walsh MJ; McAlister VC; Marotta PJ; Nashan B; Peltekian KM Liver Transpl; 2007 Aug; 13(8):1109-14. PubMed ID: 17663411 [TBL] [Abstract][Full Text] [Related]
18. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity. Hung J; McQuillan BM; Thompson PL; Beilby JP Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163 [TBL] [Abstract][Full Text] [Related]
19. Measures of obesity and metabolic syndrome in Indian Americans in northern California. Misra KB; Endemann SW; Ayer M Ethn Dis; 2006; 16(2):331-7. PubMed ID: 17682232 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over. Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]